282 related articles for article (PubMed ID: 1513782)
1. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
Starostina EG; Lobanova AM; Magomedova AK
Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
[TBL] [Abstract][Full Text] [Related]
2. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.
Gjessing HJ; Reinholdt B; Faber OK; Pedersen O
Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714
[TBL] [Abstract][Full Text] [Related]
3. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
Unger RH; Orci L
Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
[No Abstract] [Full Text] [Related]
4. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
[TBL] [Abstract][Full Text] [Related]
5. Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes.
Uitbeijerse BS; Nijhoff MF; de Koning EJP
Am J Physiol Endocrinol Metab; 2024 May; 326(5):E673-E680. PubMed ID: 38446636
[TBL] [Abstract][Full Text] [Related]
6. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
[TBL] [Abstract][Full Text] [Related]
7. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
8. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
Porte D; Kahn SE
Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
11. Islet dysfunction in non-insulin-dependent diabetes mellitus.
Kahn SE; Porte D
Am J Med; 1988 Nov; 85(5A):4-8. PubMed ID: 3057894
[TBL] [Abstract][Full Text] [Related]
12. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
13. Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction.
Halter JB; Beard JC; Porte D
Am J Physiol; 1984 Jul; 247(1 Pt 1):E47-52. PubMed ID: 6377920
[TBL] [Abstract][Full Text] [Related]
14. [Effect of i.v. tolbutamide on alpha- and beta-cell secretion in type I diabetes].
Verga S; Donatelli M; Cerasola G; Sinagra D; Inglese CG; Terrizzi C
Minerva Endocrinol; 1984; 9(3):339-42. PubMed ID: 6398400
[No Abstract] [Full Text] [Related]
15. [Hormonal function of islands of Langerhans in diabetes mellitus].
Balabolkin MI; Abrikosova SIu
Probl Endokrinol (Mosk); 1984; 30(5):16-8. PubMed ID: 6390424
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
17. Natural course of insulin sensitivity and insulin reserve in early insulin-dependent diabetes mellitus.
Linn T; Ebener K; Raptis G; Laube H; Federlin K
Metabolism; 1995 May; 44(5):617-23. PubMed ID: 7752910
[TBL] [Abstract][Full Text] [Related]
18. Transient neonatal diabetes mellitus, type 4, type 1 diabetes mellitus, or MODY: which disease is it, anyway?
AvRuskin TW; Juan CS
J Pediatr Endocrinol Metab; 2002 May; 15(5):629-36. PubMed ID: 12014522
[TBL] [Abstract][Full Text] [Related]
19. [Minidiab test to assess the functional state of pancreatic beta-cells in the children of diabetics].
Gasparian EG; Nersesian SA; Volkova EA; Kriuchkova ZV; Velikanova LI
Probl Endokrinol (Mosk); 1994; 40(6):7-10. PubMed ID: 7740043
[TBL] [Abstract][Full Text] [Related]
20. The effect of chronic hyperglycaemia on the islet B-cell responsiveness in newly diagnosed type 2 diabetes.
Gjessing HJ; Reinhold B; Pedersen O
Diabet Med; 1992; 9(7):601-4. PubMed ID: 1511564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
